『2 Minutes with Joey - RXRX Stock News』のカバーアート

2 Minutes with Joey - RXRX Stock News

2 Minutes with Joey - RXRX Stock News

著者： 2 Minutes with Joey
無料で聴く

Two minutes with Joey on Recursion (RXRX) - a quick daily recap of what the stock did today and why, in plain English. Information and entertainment only, not financial advice.Copyright 2 Minutes with Joey 社会科学
エピソード
  • RXRX Today - Jul 15: Small Gain Amid Buzz

    RXRX Today - Jul 15: Small Gain Amid Buzz
    2026/07/15
    Hey there! It’s Joey here, your friendly longtime investor, breaking down the day for you. Today we’re talking about Recursion Pharmaceuticals, ticker RXRX. It was a green day, up about 1.2%.

    So, what went down? RXRX saw a bit of a bounce today, not huge, but hey, any gain is better than a loss, right? The stock traded a bit under its usual volume, which is kinda interesting.

    Now, why the little bump? Well, there’s a couple of things buzzing around. First off, some chatter about the company reaching an “inflection point.” Sounds fancy, but basically, it means they’re hitting a turning point that could lead to some good things. Plus, Cathie Wood, you know her, right? She’s been loading up on RXRX, which gets people talking. When a big name like that backs a stock, it can stir up some excitement.

    There’s also been some positive vibes about their Q4 results, which is always a good thing. Investors love to see companies beating expectations. So, a combo of Cathie’s interest and some good numbers seems to have given RXRX a little boost today.

    Oh, and one thing to keep in mind: Recursion’s been making some noise in the biotech space. They’re working on some pretty innovative stuff, so the chatter isn't just noise; it could lead to something significant down the road.

    That’s the scoop for today! RXRX managed to hold its ground with a slight gain, and with all this buzz, it’s definitely worth keeping an eye on. Just remember, I’m here to share info and keep things fun, not to give financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • RXRX Today - Jul 14: Cathie Wood's Interest Sparks Buzz

    RXRX Today - Jul 14: Cathie Wood's Interest Sparks Buzz
    2026/07/14
    Hey there! It's Joey here, your friendly neighborhood investor, ready to break down what went down with Recursion, or RXRX, today. Spoiler alert: it was a red day, down almost 2%. Ouch!

    So, here’s the scoop. RXRX started the day with some serious hype, thanks to some buzz around Cathie Wood. You know her—she's the big-name investor who’s always making waves. People were super excited about her interest in the stock, thinking it might be a no-brainer buy. But as the day went on, folks started hitting the sell button pretty quickly. The volume was way below average, which usually means people were feeling a bit cautious.

    Now, why did it go down? Well, there’s a mix of reasons. Some chatter in the air said that while Cathie loading up on RXRX is great, it doesn’t erase the fact that the stock has been struggling for a while. It’s kind of like when your favorite band drops a new album, but you realize it’s not as good as the last one. People want to see more than just hype; they want results. Plus, there were articles floating around that mentioned RXRX still isn’t worth buying just yet, which probably made some investors think twice.

    Also, it’s worth mentioning that the stock saw a little pre-market surge after a report about a strong Q4, with the CEO saying they’ve reached an inflection point. But as we saw, that didn’t hold up throughout the day. So yeah, a bit of a rollercoaster for RXRX.

    Looking ahead, one thing to keep in mind is that there’s a Form 144 filing that came out recently. That’s usually a signal for investors to pay attention, as it can mean insiders are selling shares. It’s a mixed bag for sure.

    So, to wrap it up, RXRX had a bit of a wild ride today. Cathie Wood’s interest got people hyped, but the reality check hit hard as the day went on. Just remember, this is all for your info and entertainment, not financial advice. Stay savvy out there, and catch you later!
    続きを読む 一部表示
    2 分
  • RXRX Today - Jul 13: Stock Takes a Dip

    RXRX Today - Jul 13: Stock Takes a Dip
    2026/07/13
    Hey there! It’s Joey, your friendly neighborhood investor, here to break down what went down with Recursion, or RXRX, today. Spoiler alert: it was a red day. The stock slipped by about one and a half percent. Ouch!

    So, what happened? Well, RXRX got smoked today, dipping down a bit. You could say it was a slow bleed, and honestly, it didn’t get a ton of love from the market. There was a decent amount of trading, but it was way below the usual volume. People seemed to be hitting the sell button pretty quickly.

    Now, why did this happen? It looks like there’s some chatter about whether the stock is fully priced. An article from Simply Wall Street pointed out that while the company is making strides in its clinical progress, some folks are questioning if the current price reflects its true value. That uncertainty can scare investors off. Plus, there’s a piece from the Motley Fool calling out RXRX and other stocks as beaten-down but not worth buying right now. When you hear that kind of talk, it can definitely shake up confidence.

    On the flip side, Cathie Wood just made some moves, snagging a few stocks that she thinks are bargains. But it’s unclear if RXRX made her shopping list. So, while some big names are out there hunting for deals, it seems like RXRX was left behind today.

    Just a quick heads up: Recursion is still pushing through its clinical trials, which could be a game-changer if things go well. So, keep an eye on that, ’cause it could shift the narrative if they hit some big milestones down the line.

    Alright, that wraps it up for today! RXRX had a rough day, but that’s how the market rolls sometimes. Remember, this is just info for you to chew on, not financial advice. Stay savvy out there, and I’ll catch you later!
    続きを読む 一部表示
    2 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません